Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Tuberculosis

  Free Subscription


07.04.2020

2 Am J Epidemiol
3 Antimicrob Agents Chemother
1 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
1 Eur Respir J
15 Int J Tuberc Lung Dis
1 J Bacteriol
1 J Clin Microbiol
1 J Immunol
2 Lancet HIV
4 Lancet Infect Dis
1 Lancet Respir Med
2 N Engl J Med
1 PLoS Comput Biol
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Epidemiol

  1. SALAZAR-AUSTIN N, Dowdy DW, Chaisson RE, Golub JE, et al
    70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration.
    Am J Epidemiol. 2019 Jul 31. pii: 5542024. doi: 10.1093.
    PubMed         Abstract available

  2. NELSON KN, Gandhi NR, Mathema B, Lopman BA, et al
    Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Am J Epidemiol. 2020 Apr 3. pii: 5815310. doi: 10.1093.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  3. MALIK AA, Brooks MB, Siddiqui S, Fuad J, et al
    Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2019;63.
    PubMed         Abstract available

  4. GHIMIRE S, Maharjan B, Jongedijk EM, Kosterink JGW, et al
    Evaluation of Saliva as a Potential Alternative Sampling Matrix for Therapeutic Drug Monitoring of Levofloxacin in Patients with Multidrug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2019;63.
    PubMed         Abstract available

  5. HARIGUCHI N, Chen X, Hayashi Y, Kawano Y, et al
    OPC-167832, a novel carbostyril derivative with potent anti-tuberculosis activity as a DprE1 inhibitor.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02020.
    PubMed         Abstract available


    Clin Infect Dis

  6. THOMAS BE, Kumar JV, Chiranjeevi M, Shah D, et al
    Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications: Comparison of digital adherence data with urine isoniazid testing.
    Clin Infect Dis. 2020 Mar 28. pii: 5812993. doi: 10.1093.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  7. MENICHINI M, Lari N, Lupetti A, Rindi L, et al
    Evaluation of Xpert MTB/RIF Ultra assay for rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an Italian center.
    Eur J Clin Microbiol Infect Dis. 2020 Mar 31. pii: 10.1007/s10096-020-03867.
    PubMed        


    Eur Respir J

  8. HAMADA Y, Figueroa C, Martin-Sanchez M, Falzon D, et al
    The safety of isoniazid tuberculosis preventive treatment in pregnant and postpartum women: systematic review and meta-analysis.
    Eur Respir J. 2020;55.
    PubMed         Abstract available


    Int J Tuberc Lung Dis

  9. SILVA A, Ponte C, Antas PRZ
    What a difference a strain makes!
    Int J Tuberc Lung Dis. 2019;23:874.
    PubMed        

  10. GUNASEKERA K, Cohen T, Gao W, Ayles H, et al
    Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey.
    Int J Tuberc Lung Dis. 2020;24:340-346.
    PubMed         Abstract available

  11. NGABONZIZA JS, Habimana YM, Decroo T, Migambi P, et al
    Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
    Int J Tuberc Lung Dis. 2020;24:329-339.
    PubMed         Abstract available

  12. DEDICOAT M
    Where next with for vitamin D and tuberculosis?
    Int J Tuberc Lung Dis. 2020;24:265.
    PubMed        

  13. JANSSON L, Shedrawy J, Lonnroth K, Bruchfeld J, et al
    Latent tuberculosis in pregnant women: a patient perspective.
    Int J Tuberc Lung Dis. 2020;24:310-315.
    PubMed         Abstract available

  14. LOPEZ-MEDINA EM, Sainz T, de Ory SJ, Mellado-Pena MJ, et al
    Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study).
    Int J Tuberc Lung Dis. 2020;24:303-309.
    PubMed         Abstract available

  15. WANG M, Liu F, Li Q, Yin Q, et al
    Quality assessment of guidelines for the management of Mycobacterium tuberculosis infection in children.
    Int J Tuberc Lung Dis. 2020;24:287-294.
    PubMed         Abstract available

  16. ARNEDO-PENA A, Juan-Cerdan JV, Romeu-Garcia M, Sorribes-Segura S, et al
    Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain.
    Int J Tuberc Lung Dis. 2020;24:278-286.
    PubMed         Abstract available

  17. KOHLENBERG A, Kodmon C, van den Boom M, van der Werf MJ, et al
    Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?
    Int J Tuberc Lung Dis. 2020;24:347-352.
    PubMed         Abstract available

  18. YATES TA, Tomlinson LA, Douglas IJ
    Proton pump inhibitors and tuberculosis risk.
    Int J Tuberc Lung Dis. 2020;24:353-354.
    PubMed        

  19. HASKER E, Assoumani Y, Mzembaba A, Zakir AM, et al
    Using a geographic information system as a management tool for tuberculosis control.
    Int J Tuberc Lung Dis. 2020;24:354-356.
    PubMed        

  20. DOWDY DW
    The urgent need to improve clinical practice guidelines for pediatric tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:264.
    PubMed        

  21. NDAKIDEMI E, Emerson C, Medley A, Ngowi B, et al
    Health care worker perspectives on TB case finding and HIV services among pediatric TB patients in Tanzania.
    Int J Tuberc Lung Dis. 2019;23:811-816.
    PubMed         Abstract available

  22. BONSU F, Addo KK, Alebachew Z, Gyapong J, et al
    National population-based tuberculosis prevalence survey in Ghana, 2013.
    Int J Tuberc Lung Dis. 2020;24:321-328.
    PubMed         Abstract available

  23. REICHLER MR, Hirsch-Moverman Y
    Antenatal diagnosis of latent tuberculosis infection and post-partum treatment: patient perspectives.
    Int J Tuberc Lung Dis. 2020;24:266-267.
    PubMed        


    J Bacteriol

  24. BOSSERMAN RE, Nicholson KR, Champion MM, Champion PA, et al
    A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.
    J Bacteriol. 2019;201.
    PubMed         Abstract available


    J Clin Microbiol

  25. BUONSENSO D, Delogu G, Perricone C, Grossi R, et al
    Accuracy of QuantiFERON-TB Gold-PLUS Test for the Diagnosis of Mycobacterium tuberculosis infection in Children.
    J Clin Microbiol. 2020 Mar 30. pii: JCM.00272-20. doi: 10.1128/JCM.00272.
    PubMed         Abstract available


    J Immunol

  26. YANG Q, Zhang M, Chen Q, Chen W, et al
    Cutting Edge: Characterization of Human Tissue-Resident Memory T Cells at Different Infection Sites in Patients with Tuberculosis.
    J Immunol. 2020 Mar 30. pii: jimmunol.1901326. doi: 10.4049/jimmunol.1901326.
    PubMed         Abstract available


    Lancet HIV

  27. DOOLEY KE, Savic R, Gupte A, Marzinke MA, et al
    Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
    Lancet HIV. 2020 Mar 30. pii: S2352-3018(20)30032.
    PubMed         Abstract available

  28. MAYANJA-KIZZA H
    Prevention of tuberculosis in HIV infection with novel drugs.
    Lancet HIV. 2020 Mar 30. pii: S2352-3018(20)30074.
    PubMed        


    Lancet Infect Dis

  29. MARAIS BJ, Chakaya J, Swaminathan S, Fox GJ, et al
    Tackling long-term morbidity and mortality after successful tuberculosis treatment.
    Lancet Infect Dis. 2020 Mar 23. pii: S1473-3099(20)30167.
    PubMed        

  30. ZUMLA A, Yeboah-Manu D, Michel AL, Azhar EI, et al
    Zoonotic tuberculosis-a call for an open One Health debate.
    Lancet Infect Dis. 2020 Mar 23. pii: S1473-3099(20)30166.
    PubMed        

  31. MUSHTAQ A
    New guidelines for latent tuberculosis.
    Lancet Infect Dis. 2020;20:414.
    PubMed        

  32. BANERJI JS
    Primary tuberculosis of the glans penis in an immunocompetent male.
    Lancet Infect Dis. 2020;20:509.
    PubMed        


    Lancet Respir Med

  33. WINGFIELD T, Cuevas LE, MacPherson P, Millington KA, et al
    Tackling two pandemics: a plea on World Tuberculosis Day.
    Lancet Respir Med. 2020 Mar 24. pii: S2213-2600(20)30151.
    PubMed        


    N Engl J Med

  34. DE JAGER VR, Dawson R, van Niekerk C, Hutchings J, et al
    Telacebec (Q203), a New Antituberculosis Agent.
    N Engl J Med. 2020;382:1280-1281.
    PubMed        

  35. ZAHEEN A, Bloom BR
    Tuberculosis in 2020 - New Approaches to a Continuing Global Health Crisis.
    N Engl J Med. 2020;382:e26.
    PubMed        


    PLoS Comput Biol

  36. BROOKS-POLLOCK E, Danon L, Korthals Altes H, Davidson JA, et al
    A model of tuberculosis clustering in low incidence countries reveals more transmission in the United Kingdom than the Netherlands between 2010 and 2015.
    PLoS Comput Biol. 2020;16:e1007687.
    PubMed         Abstract available


    PLoS One

  37. SRIVASTAVA S, Chapagain M, Gumbo T
    Effect of specimen processing, growth supplement, and different metabolic population on Mycobacterium tuberculosis laboratory diagnosis.
    PLoS One. 2020;15:e0230927.
    PubMed         Abstract available

  38. SUN HY, Wang JY, Chen YC, Hsueh PR, et al
    Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan.
    PLoS One. 2020;15:e0230067.
    PubMed         Abstract available

  39. ARINAMINPATHY N, Gomez GB, Sachdeva KS, Rao R, et al
    The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
    PLoS One. 2020;15:e0230808.
    PubMed         Abstract available

  40. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  41. OYAS O, Borrell S, Trauner A, Zimmermann M, et al
    Model-based integration of genomics and metabolomics reveals SNP functionality in Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 1915551117.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: